Delivery Order SPE2DB22D3016-SPE2DB25FBDY2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Sevoflurane Inhalation Liquid in 250ml units with a ceiling value of $1,656.66. This firm fixed-price delivery order, which must be completed by July 18, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Sevoflurane Inhalation Liquid in 250 milliliter quantities. This competitively awarded, non-set-aside contract carries a ceiling value of $1,414.08 and utilizes firm fixed pricing, with an ultimate completion date of September 10, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,979.33 to AmerisourceBergen Drug Corp on April 25, 2025, for the supply of Sevoflurane Inhalation Liquid in 250ml quantities. This is a firm fixed-price contract with an ultimate completion date of April 28, 2025, and carries no set-aside designation, indicating it was competitively awarded. The award was placed to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. Sevoflurane is a volatile...
- The Defense Logistics Agency awarded a $1,423.80 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Sevoflurane Inhalation Liquid in 250ml quantities. This firm fixed-price delivery order represents a non-competitive set-aside award and is scheduled for completion by August 1, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Sevoflurane is a volatile anesthetic commonly used in surgical and medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Sevoflurane Inhalation Liquid in 250ml quantities, with a ceiling value of $3,009.44. This was a firm fixed price contract awarded on September 9, 2025, with an ultimate completion date of September 10, 2025. The award represents a non-set-aside, competitively awarded procurement with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order is issued under...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Sevoflurane Inhalation Liquid in 250ml units, with a ceiling value of $2,828.16. This delivery order represents a firm fixed price contract with no set-aside designation and is scheduled for ultimate completion on July 25, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Sevoflurane Inhalation Liquid in 250ml quantities, with a contract ceiling value of $1,414.08. This award, issued on September 15, 2025, represents a firm fixed price delivery order with an ultimate completion date of September 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded competitively without a...
- The Defense Logistics Agency awarded a $1,969.54 delivery order to AmerisourceBergen Drug Corp for 250ml of Sevoflurane inhalation liquid, with an ultimate completion date of June 25, 2025. This is a firm fixed price, non-set-aside contract executed on June 24, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Sevoflurane Inhalation Liquid in 250mL quantities, with a ceiling value of $4,649.76. This firm fixed price delivery order, issued on August 28, 2025, represents a non-competitive set-aside award and is scheduled for ultimate completion by August 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Sevoflurane Inhalation Liquid in 250ml quantities, with a ceiling value of $1,885.44 and a firm fixed price structure. The delivery order, which represents a non-competitive set-aside award, is scheduled for completion by September 16, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBDY2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Sevoflurane Inhalation Liquid in 250ml quantities, valued at $3,869.12. This non-set-aside, competitively awarded contract carries a firm fixed price structure with an ultimate completion date of August 5, 2025. The work will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Sevoflurane is a volatile anesthetic commonly used in surgical and medical procedures, making this delivery critical to military healthcare operations and readiness. This delivery order represents a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which holds a potential value of $999,999,999.00 through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp has demonstrated substantial capability in fulfilling federal medical procurement requirements through its extensive portfolio of drug and medical supply deliveries to the Defense Health Agency and other military healthcare systems. The company's established presence as a prime vendor within DLA's global pharmaceutical support program enables efficient delivery of specialized medical commodities essential to military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 8/4/25 |